CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
WaveLight EX500 excimer laser system +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04805593
NCT04805593N/ACompleted

Clinical Investigation of the WaveLight® EX500 Excimer Laser for Hyperopic LASIK

Alcon Research·interventional·Posted Mar 18, 2021·Updated Aug 21, 2024

In Brief

A clinical study evaluating WaveLight EX500 excimer laser system and LASIK for Hyperopia and Hyperopic Astigmatism. Completed, enrolled 44 participants across 5 sites.

Detailed Summary

The purpose of this study is to collect efficacy and safety data on the WaveLight EX500 excimer laser system for the correction of hyperopia with and without astigmatism by laser in situ keratomileusis (LASIK) treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 18, 2021
Enrollment StartApr 28, 2021
Primary CompletionMay 2, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 5.3 years ago

Interventions

WaveLight EX500 excimer laser systemdevice

FDA approved stationary scanning-spot excimer laser system used during refractive surgery for the treatment of myopia, myopic astigmatism, hyperopia, hyperopic astigmatism, and mixed astigmatism. For this clinical study, the Wavefront Optimized (WFO) Ablation profile of the WaveLight EX500 excimer laser system will be used for bilateral LASIK treatment of hyperopia with and without astigmatism.

LASIKprocedure

Procedure that reshapes the front part of the eye (cornea) so that light traveling through it is properly focused on the back part of the eye (retina). The procedure will be performed using the WaveLight EX500 excimer laser system.